UA94580C2 - Аналог 39-дезметоксирапамицина, способный преодолевать гематоэнцефалический барьер, для лечения патологического состояния, вызванного нейрогенным повреждением или заболеванием - Google Patents
Аналог 39-дезметоксирапамицина, способный преодолевать гематоэнцефалический барьер, для лечения патологического состояния, вызванного нейрогенным повреждением или заболеваниемInfo
- Publication number
- UA94580C2 UA94580C2 UAA200711241A UAA200711241A UA94580C2 UA 94580 C2 UA94580 C2 UA 94580C2 UA A200711241 A UAA200711241 A UA A200711241A UA A200711241 A UAA200711241 A UA A200711241A UA 94580 C2 UA94580 C2 UA 94580C2
- Authority
- UA
- Ukraine
- Prior art keywords
- disease
- treatment
- medical condition
- brain barrier
- increased blood
- Prior art date
Links
- DIEORUOOFDNDCG-UHFFFAOYSA-N 41-desmethoxyrapamycin 31-OTMS Natural products C1C(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C(C)C(OC)CC(O2)CCC(C)C2(O)C(=O)C(=O)N2CCCCC2C(=O)OC1C(C)CC1CCC(O)CC1 DIEORUOOFDNDCG-UHFFFAOYSA-N 0.000 title 1
- 208000027418 Wounds and injury Diseases 0.000 title 1
- 230000008499 blood brain barrier function Effects 0.000 title 1
- 210000001218 blood-brain barrier Anatomy 0.000 title 1
- 230000006378 damage Effects 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 208000014674 injury Diseases 0.000 title 1
- 230000001537 neural effect Effects 0.000 title 1
- 230000035699 permeability Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0504995.2A GB0504995D0 (en) | 2005-03-11 | 2005-03-11 | Use of a compound |
Publications (1)
Publication Number | Publication Date |
---|---|
UA94580C2 true UA94580C2 (ru) | 2011-05-25 |
Family
ID=34508874
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200711241A UA94580C2 (ru) | 2005-03-11 | 2006-10-03 | Аналог 39-дезметоксирапамицина, способный преодолевать гематоэнцефалический барьер, для лечения патологического состояния, вызванного нейрогенным повреждением или заболеванием |
Country Status (5)
Country | Link |
---|---|
US (2) | US7183289B2 (ru) |
CN (1) | CN101180054A (ru) |
GB (1) | GB0504995D0 (ru) |
RU (1) | RU2428982C2 (ru) |
UA (1) | UA94580C2 (ru) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102144961A (zh) * | 2003-09-18 | 2011-08-10 | 参天制药株式会社 | 经巩膜递送 |
US8663639B2 (en) * | 2005-02-09 | 2014-03-04 | Santen Pharmaceutical Co., Ltd. | Formulations for treating ocular diseases and conditions |
BRPI0608152A2 (pt) * | 2005-02-09 | 2009-11-10 | Macusight Inc | formulações para tratamento ocular |
US20100061994A1 (en) * | 2005-03-11 | 2010-03-11 | Rose Mary Sheridan | Medical uses of 39-desmethoxyrapamycin and analogues thereof |
GB0504994D0 (en) * | 2005-03-11 | 2005-04-20 | Biotica Tech Ltd | Novel compounds |
KR20140093764A (ko) | 2006-02-09 | 2014-07-28 | 산텐 세이야꾸 가부시키가이샤 | 안정한 제제와 그 제조 및 사용 방법 |
CN103127100A (zh) * | 2006-03-23 | 2013-06-05 | 参天制药株式会社 | 用于与血管通透性有关的疾病或病症的制剂和方法 |
GB0618403D0 (en) * | 2006-09-19 | 2006-11-01 | Leuven K U Res & Dev | Treatment of amyotrophic lateral sclerosis |
TW200845960A (en) * | 2007-04-05 | 2008-12-01 | Wyeth Corp | Wortmannin-rapalog conjugate and uses thereof |
US20080249123A1 (en) * | 2007-04-05 | 2008-10-09 | Wyeth | Wortmannin-rapamycin conjugate and uses thereof |
US20080265343A1 (en) * | 2007-04-26 | 2008-10-30 | International Business Machines Corporation | Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof |
US8754094B2 (en) * | 2007-08-15 | 2014-06-17 | The Research Foundation Of State University Of New York | Methods for heat shock protein dependent cancer treatment |
CA2716321A1 (en) * | 2008-02-21 | 2009-08-27 | The Regents Of The University Of Colorado | Methods for treating cancer using combination therapy |
GB201122305D0 (en) * | 2011-12-23 | 2012-02-01 | Biotica Tech Ltd | Novel compound |
KR20160104612A (ko) | 2013-07-26 | 2016-09-05 | 업데이트 파마 인코포레이트 | 비산트렌의 치료 효과 개선용 조성물 |
WO2019157382A1 (en) * | 2018-02-09 | 2019-08-15 | Mount Tam Therapeutics, Inc. | Rapamycin analog for prevention and/or treatment of neurodegenerative conditions |
US11633399B2 (en) | 2018-12-25 | 2023-04-25 | Sol-Gel Technologies Ltd. | Treatment of skin disorders with compositions comprising an EGFR inhibitor |
CN111007161B (zh) * | 2019-11-04 | 2021-03-26 | 中南大学 | 一种预测甲氨蝶呤药效的肽段组合物及其定量检测方法与检测试剂盒 |
WO2022179575A1 (zh) * | 2021-02-25 | 2022-09-01 | 中以海德人工智能药物研发股份有限公司 | 雷帕霉素在治疗或预防乙型肝炎中的应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5708002A (en) * | 1991-09-05 | 1998-01-13 | Abbott Laboratories | Macrocyclic immunomodulators |
JP3140228B2 (ja) | 1992-02-17 | 2001-03-05 | ファイザー製薬株式会社 | 新規な大環状ラクトンおよびその生産菌 |
GB9315914D0 (en) * | 1993-07-31 | 1993-09-15 | Smithkline Beecham Plc | Novel compound |
AU735648B2 (en) | 1996-07-12 | 2001-07-12 | Ariad Pharmaceuticals, Inc. | Materials and method for treating or preventing pathogenic fungal infection |
US6273913B1 (en) * | 1997-04-18 | 2001-08-14 | Cordis Corporation | Modified stent useful for delivery of drugs along stent strut |
US6485514B1 (en) * | 1997-12-12 | 2002-11-26 | Supergen, Inc. | Local delivery of therapeutic agents |
ES2705016T3 (es) * | 2001-02-19 | 2019-03-21 | Novartis Int Pharmaceutical Ag | Derivado de rapamicina para el tratamiento de cáncer de pulmón |
CA2472341C (en) * | 2002-02-01 | 2011-06-21 | Ariad Gene Therapeutics, Inc. | Phosphorus-containing compounds & uses thereof |
US7300942B2 (en) | 2002-07-16 | 2007-11-27 | Biotica Technology Limited | Production of polyketides and other natural products |
WO2006095173A2 (en) * | 2005-03-11 | 2006-09-14 | Biotica Technology Limited | Medical uses of 39-desmethoxyrapamycin and analogues thereof |
-
2005
- 2005-03-11 GB GBGB0504995.2A patent/GB0504995D0/en not_active Ceased
- 2005-04-01 US US11/097,605 patent/US7183289B2/en not_active Expired - Fee Related
-
2006
- 2006-03-10 CN CNA2006800126751A patent/CN101180054A/zh active Pending
- 2006-03-10 RU RU2007137669/15A patent/RU2428982C2/ru not_active IP Right Cessation
- 2006-10-03 UA UAA200711241A patent/UA94580C2/ru unknown
-
2007
- 2007-01-10 US US11/651,669 patent/US7655673B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
GB0504995D0 (en) | 2005-04-20 |
US7655673B2 (en) | 2010-02-02 |
RU2007137669A (ru) | 2009-04-20 |
US7183289B2 (en) | 2007-02-27 |
US20070184075A1 (en) | 2007-08-09 |
RU2428982C2 (ru) | 2011-09-20 |
CN101180054A (zh) | 2008-05-14 |
US20060205757A1 (en) | 2006-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA94580C2 (ru) | Аналог 39-дезметоксирапамицина, способный преодолевать гематоэнцефалический барьер, для лечения патологического состояния, вызванного нейрогенным повреждением или заболеванием | |
MY145439A (en) | Use of flibanserin for the treatment of pre-menopausal sexual desire disorders | |
SG145693A1 (en) | Amino acid prodrugs | |
MXPA06013039A (es) | El tratamiento de enfermedad respiratoria. | |
IL175762A0 (en) | Use of substituted 2-aminotetralines for the preventative treatment of parkinson's disease | |
HK1111083A1 (en) | 3,11b cis dihydrotetrabanezine for the treatment of schizophrenia and other psychoses | |
MX2007012538A (es) | Uso de lactobacillus gg en la manufactura de un medicamento para la prevencion o tratamiento de alergias respiratorias. | |
TW200700071A (en) | Novel use | |
UA96926C2 (ru) | Применение sdf-1 для лечения и/или профилактики неврологических заболеваний | |
UA97401C2 (ru) | Экструдат с улучшенной маскировкой вкуса | |
MA32841B1 (fr) | Composés de cycloundeca depsipeptides et leur utilisation comme médicament | |
EP2446887A3 (en) | Use of danazol for the treatment of Alzheimer's disease | |
NO20076405L (no) | Anvendelse av 24-nor-UDCA | |
HK1110211A1 (ru) | ||
TW200640467A (en) | Compounds and uses thereof | |
WO2009043858A3 (en) | Methods for treating and diagnosing a cancer secreting cath-d or alzheimer's disease | |
WO2006111720A3 (en) | Use | |
UA92586C2 (ru) | Лечение или предотвращение респираторных вирусных инфекций с помощью иммуномодуляторов | |
PL1612210T3 (pl) | Nowe analogi nitrobenzylotioinozyny | |
UA99093C2 (ru) | Применение фенофибрата или его производного для лечения диабетической ретинопатии | |
ZA200800999B (en) | Use of N-dibenz (b,f)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of muscular dystrophy | |
WO2008034202A3 (en) | Use of ivermectin and derivates thereof for the treatment of amyotrophic lateral sclerosis | |
UA96278C2 (ru) | Применение флибансерина для лечения расстройств полового влечения в предклимактерический период | |
ATE503527T1 (de) | Selen-haltige medikamente gegen endotheliale gefässerkrankungen | |
ITTV20050186A1 (it) | Lettino per l'abbronzatura del corpo. |